🇺🇸 FDA
Pipeline program

Bryhali

V01-122A-401

Phase 2 small_molecule active

Quick answer

Bryhali for Plaque Psoriasis is a Phase 2 program (small_molecule) at Bausch Health Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Bausch Health Ireland Limited
Indication
Plaque Psoriasis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials